Genetically modified vaccine


Most vaccines consist of viruses that have been attenuated, disabled, weakened or killed in some way so that their virulent properties are no longer effective. A simple genetically modified vaccine, based on a thymidine kinase deficient mutant of pseudorabies virus was reportedly available as early as 2001 as a commercial vaccine to control Aujeszky's disease in Europe, North America and Japan.[1]

References

  1. ↑ Stephenson, John (2001). "Genetically Modified Viruses Vaccines by Design". Current Pharmaceutical Biotechnology. 2 (1): 47–76. doi:10.2174/1389201013378815. PMID 11482348.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.